LOTA S ZOTH Insider Trading $NLNK LUMOS PHARMA, INC.
Get free email notifications about insider trading for LOTA S ZOTH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOTA S ZOTH. LOTA S ZOTH is Chief Financial Officer in MEDIMMUNE INC /DE ($MEDI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in NEWLINK GENETICS CORP ($NLNK) and Director in Orexigen Therapeutics, Inc. ($OREX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Zymeworks Inc. ($ZYME) and CHIEF SCIENTIFIC OFFICER in Spark Therapeutics, Inc. ($ONCE) and Director in Spark Therapeutics, Inc. ($ONCE) and Director in 89bio, Inc. ($ETNB).
LOTA S ZOTH in LUMOS PHARMA, INC.
Trading Symbol: NLNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 1,820 shares
Current Value: $24,879
Latest Transaction: Apr 07 2020
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LOTA S ZOTH in LUMOS PHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, HPTX, GEB, NLNK, MEDI, OREX, ONCE, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Zoth Lota S. | Director | Grant | A | 0.00 | 709 | 0 | 1,820 | 1.1 K to 1.8 K (+63.82 %) |
Jan 06 2020 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Grant | A | 0.00 | 2,100 | 0 | 10,006 | 7.9 K to 10 K (+26.56 %) |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 2,392 | 4,234 | 2,392 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 4,783 | 51,561 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 17,773 | 191,593 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,571 | 6,321 | 3,571 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 10,713 | 142,483 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,968 | 7,023 | 3,968 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 11,904 | 158,323 | 0 | |
May 14 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
May 25 2018 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
May 16 2017 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
May 04 2015 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 44.60 | 3,643 | 162,478 | 3,643 | |
May 04 2015 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Grant | A | 0.00 | 1,962 | 0 | 7,906 | 5.9 K to 7.9 K (+33.01 %) |
Page: 1